1. Home
  2. KALA vs ARKR Comparison

KALA vs ARKR Comparison

Compare KALA & ARKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • ARKR
  • Stock Information
  • Founded
  • KALA 2009
  • ARKR 1983
  • Country
  • KALA United States
  • ARKR United States
  • Employees
  • KALA N/A
  • ARKR N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • ARKR Restaurants
  • Sector
  • KALA Health Care
  • ARKR Consumer Discretionary
  • Exchange
  • KALA Nasdaq
  • ARKR Nasdaq
  • Market Cap
  • KALA 26.2M
  • ARKR 25.3M
  • IPO Year
  • KALA 2017
  • ARKR N/A
  • Fundamental
  • Price
  • KALA $1.67
  • ARKR $7.15
  • Analyst Decision
  • KALA Buy
  • ARKR
  • Analyst Count
  • KALA 3
  • ARKR 0
  • Target Price
  • KALA $31.50
  • ARKR N/A
  • AVG Volume (30 Days)
  • KALA 2.7M
  • ARKR 4.7K
  • Earning Date
  • KALA 11-11-2025
  • ARKR 08-11-2025
  • Dividend Yield
  • KALA N/A
  • ARKR N/A
  • EPS Growth
  • KALA N/A
  • ARKR N/A
  • EPS
  • KALA N/A
  • ARKR N/A
  • Revenue
  • KALA N/A
  • ARKR $171,834,000.00
  • Revenue This Year
  • KALA N/A
  • ARKR N/A
  • Revenue Next Year
  • KALA N/A
  • ARKR N/A
  • P/E Ratio
  • KALA N/A
  • ARKR N/A
  • Revenue Growth
  • KALA N/A
  • ARKR N/A
  • 52 Week Low
  • KALA $1.10
  • ARKR $6.38
  • 52 Week High
  • KALA $20.60
  • ARKR $17.76
  • Technical
  • Relative Strength Index (RSI)
  • KALA 27.87
  • ARKR 47.71
  • Support Level
  • KALA $1.26
  • ARKR $7.10
  • Resistance Level
  • KALA $1.69
  • ARKR $7.47
  • Average True Range (ATR)
  • KALA 1.14
  • ARKR 0.18
  • MACD
  • KALA -1.93
  • ARKR 0.05
  • Stochastic Oscillator
  • KALA 2.80
  • ARKR 45.33

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About ARKR Ark Restaurants Corp.

Ark Restaurants Corp owns and operates around 17 restaurants and bars, 16 fast food concepts, and catering operations in the USA. The Las Vegas operations include New York Hotel & Casino Resort, hotel room service operations, banquet facilities, employee dining room, food court concepts, and a restaurant within the Planet Hollywood Resort and Casino. It operates a restaurant and a bar in the Resorts Atlantic City Hotel and Casino and a restaurant in the Tropicana Hotel and Casino. The Florida operations include The Rustic Inn in Dania Beach, Shuckers in Jensen Beach, JB's on the Beach in Deerfield Beach, The Blue Moon Fish Company in Fort Lauderdale, and fast food facilities in Tampa and Hollywood. In Alabama, it operates Original Oyster Houses in Gulf Shores and Spanish Fort.

Share on Social Networks: